Use of Multiple Doses of Convalescent Plasma in Mechanically Intubated Patients With COVID-19

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 6, 2020

Primary Completion Date

September 29, 2020

Study Completion Date

October 14, 2020

Conditions
COVID-19
Interventions
BIOLOGICAL

Multiple doses of anti-SARS-CoV-2 Convalescent Plasma

SARS-CoV-2 Convalescent Plasma(1-2 units; \~300-600 mL with the presence of IgG anti-SARS-CoV-2.

Trial Locations (1)

Unknown

1. Complejo Hospitalario Metropolitano Arnulfo Arias Madrid, Caja de Seguro Social, Panama City

All Listed Sponsors
collaborator

Complejo Hospitalario Dr. Arnulfo Arias Madrid

OTHER

collaborator

Hospital Santo Tomas

OTHER

collaborator

Hospital Punta Pacífica, Pacífica Salud

UNKNOWN

collaborator

Insituto Conmemorativo Gorgas de Estudios para la Salud

UNKNOWN

collaborator

Sociedad Panameña de Hematología

UNKNOWN

collaborator

Institute of Scientific Research and High Technology Services (INDICASAT AIP)

UNKNOWN

collaborator

University of Panama

UNKNOWN

collaborator

Sistema Nacional de Investigación de Panamá

UNKNOWN

lead

Hospital Regional Dr. Rafael Estévez

OTHER

NCT05595538 - Use of Multiple Doses of Convalescent Plasma in Mechanically Intubated Patients With COVID-19 | Biotech Hunter | Biotech Hunter